Athanor Capital, LP - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
Athanor Capital, LP ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$624,000
-32.9%
24,398
-42.2%
0.01%
-33.3%
Q4 2020$930,000
+13.6%
42,197
-7.3%
0.02%
-32.3%
Q3 2020$819,000
+309.5%
45,501
+477.3%
0.03%
+210.0%
Q2 2020$200,000
-62.7%
7,882
-67.6%
0.01%
-58.3%
Q4 2019$536,000
+130.0%
24,350
+64.5%
0.02%
-20.0%
Q2 2019$233,00014,8000.03%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,813,392$67,676,00017.58%
Bain Capital Life Sciences Investors, LLC 3,080,237$114,954,0007.53%
RTW INVESTMENTS, LP 7,521,859$280,716,0004.24%
DAFNA Capital Management LLC 510,756$19,061,0003.99%
SILVERARC CAPITAL MANAGEMENT, LLC 229,892$8,580,0003.83%
Parkman Healthcare Partners LLC 304,686$11,371,0002.49%
Evolutionary Tree Capital Management, LLC 141,324$5,274,0002.43%
Eagle Health Investments LP 161,125$6,013,0002.06%
Lombard Odier Asset Management (Switzerland) SA 636,011$23,736,0001.20%
Woodline Partners LP 1,000,325$37,332,0000.70%
View complete list of DICERNA PHARMACEUTICALS INC shareholders